NOVAPHARM Trading

What NOVAPHARM Trading does

NOVAPHARM Trading (legal entity SARL NOVAPHARM Trading) is an Algerian pharmaceutical laboratory founded in 1995 and headquartered in Bouismail, Tipaza. The company manufactures and distributes a portfolio of pharmaceutical medications and complementary dietary supplements, all produced under Good Manufacturing Practices (GMP) and certified to ISO 9001:2015 quality management standards. It also operates a pharmacovigilance service for adverse drug event monitoring and reporting, in line with regulatory requirements. The company is structured as a private limited company (SARL) with 51-100 employees and serves three primary customer segments: individual patients, hospitals, and healthcare professionals across Algeria. The business model is conventional pharmaceutical manufacturing and distribution: products are sold to healthcare providers and through hospital channels, with the pharmacovigilance service offered as a complementary value-add supporting patient safety. The company operates a single manufacturing site in Tipaza, with no disclosed subsidiaries, parent company, funding rounds, or partnership agreements. The website is a basic brochure-style presence with a contact form, pharmacovigilance reporting channel, and a privacy policy compliant with Algerian Law No. 18-07. There is no evidence of international expansion, technology partnerships, or external investment.

Name

NOVAPHARM Trading

Legal name

SARL NOVAPHARM Trading

Website

https://novapharm-dz.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

51–100 employees

Short description

Founded in 1995, NOVAPHARM Trading is an Algerian pharmaceutical laboratory that manufactures medications and dietary supplements under GMP and ISO 9001:2015 standards, serving patients, hospitals, and healthcare professionals across Algeria.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical manufacturing
• Dietary supplements
• Pharmacovigilance services
• GMP medications
• Drug safety monitoring

Headquarters

HQ city

Bouismail , Tipaza

HQ country

Algeria

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Core offering

Laboratoires NOVAPHARM Trading is an Algerian pharmaceutical laboratory that manufactures and supplies a wide range of medications and complementary dietary supplements under GMP manufacturing standards and an ISO 9001:2015 certified quality management system. The company also provides pharmacovigilance services dedicated to detecting, evaluating, and preventing adverse drug effects to support safe therapeutic care.

Product overview

NOVAPHARM Trading operates as a pharmaceutical laboratory offering a unified portfolio centered on medications and dietary supplements. Their product offering consists of a wide range of pharmaceutical medications and complementary dietary supplements, both manufactured under strict GMP standards and ISO 9001:2015 quality management. In addition to their core products, they provide pharmacovigilance services to ensure patient safety and therapeutic effectiveness. The company targets patients, hospitals, and healthcare professionals across Algeria.

Differentiator

Problem solved

Functional benefit

Products and services

• Medications
• Dietary Supplements
• Pharmacovigilance Services

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Regional players

• Hikma Pharmaceuticals: Leading MENA-headquartered pharmaceutical company with extensive generics and branded manufacturing across the Middle East and North Africa. Comparable as a regional finished-dose pharma manufacturer operating in adjacent MENA markets that NOVAPHARM could potentially serve or compete with for export opportunities.
• EIPICO (Egyptian International Pharmaceutical Industries Company): Major Egyptian pharmaceutical manufacturer producing generics, biosimilars, and OTC medications. Comparable as a North African finished-dose pharma manufacturer with GMP-certified operations serving patients, hospitals, and HCPs in the broader MENA region.
• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer producing generics, branded medications, and consumer health products across the MENA region. Comparable as a regional finished-dose pharma manufacturer with GMP operations serving similar therapeutic categories in North Africa-adjacent markets.
• Pharco Pharmaceuticals: One of Egypt's largest pharmaceutical manufacturers, producing generics, branded medications, and dietary supplements with exports across MENA and Africa. Comparable as a regional manufacturer combining finished-dose medications with dietary supplements under GMP, serving similar hospital and retail channels.
• SPIMACO Addwaeih: Saudi Arabia's leading pharmaceutical manufacturer producing generics, specialty pharma, and nutraceutical products. Comparable as a regional finished-dose manufacturer with GMP and ISO certifications serving MENA markets including Algeria-adjacent geographies.

Emerging players

• Cipla: Global pharmaceutical manufacturer with strong presence in Africa producing affordable generics, OTC medications, and consumer health products. Comparable as an emerging player targeting the African pharmaceutical market with GMP manufacturing and dietary supplements portfolio, with growing presence in North Africa.
• Strides Pharma: India-headquartered pharmaceutical manufacturer producing generics and finished dosage forms with strong regulatory presence in emerging markets including Africa. Comparable as an emerging player with GMP manufacturing capabilities targeting African and MENA markets for generic medications.

Direct peers

• Saidal: Algeria's leading state-owned pharmaceutical manufacturer, producing generics, OTC medications, and dietary supplements across multiple therapeutic categories. Directly comparable as a domestic Algerian finished-dose pharma manufacturer targeting patients, hospitals, and HCPs, though at significantly larger scale.

Broad incumbents

• Merck Algeria: Global pharmaceutical and life sciences company with Algerian operations distributing medications and pharmaceutical products. Comparable as a broader incumbent operating in the same Algerian market targeting hospitals and healthcare professionals, though with a wider portfolio and international R&D backing.
• Sanofi Algeria: Multinational pharmaceutical major with established Algerian operations manufacturing and distributing a broad portfolio of branded and generic medications. Comparable as a competitor in the Algerian pharmaceutical market serving hospitals, pharmacies, and HCPs, though at significantly larger scale and with broader therapeutic breadth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/sarl-novapharm-trading

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NOVAPHARM Trading